ABVX — Abivax SA Share News
0.000.00%
Last trade - 00:00Brief: Euronext Includes Maurel et Prom, Mersen In SBF 120, Excludes Elior Group, Nexity
Abivax shares sink after key trial results for inflammatory bowel drug (updated)
Abivax shares sink after key trial results for inflammatory bowel drug
Abivax seen falling up to 25% after key trial for inflammatory bowel drug
Abivax's inflammatory bowel drug meets main goal of late stage trial
NASDAQ RESUMED AT 04:30 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:01 PM
Brief: Abivax Presents First Quarter 2026 Financial Results
Brief: Abivax Announces Repurchase Of Royalty Certificates And Pricing Of $45 Mln Offering Of American Depositary Shares
Media: Abivax CEO says company in no rush for a deal - CNBC
Brief: Abivax Announces Full Year 2025 Financial Results And Provides Business Updates
France's Abivax 2025 net loss widens on higher R&D and G&A costs
Brief: Abivax Announces Full Year 2025 Financial Results And Provides Business Updates
Abivax denies AstraZeneca takeover rumors reported by French media (updated)
Abivax spokesperson denies takeover rumors reported by French media
Abivax shares soar after renewed takeover rumours
Abivax CEO dismisses 'noise' around rumored Eli Lilly bid
Abivax rises as another media report feeds M&A chatter
France has had no request for investment approval in biotech Abivax - official (updated)